MNZO OTC
Manzo Pharmaceuticals, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -50.0%
5Y: -66.7%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.000001-0.0001
Volume262,900
Avg Volume174,944
Beta-0.54
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOKenneth Manzo
Employees12
SectorHealthcare
IndustryMedical - Pharmaceuticals
IPO Date1998-12-31
Websitelactofreedom.com
PO Box 107
Milford, PA 18337
US
Milford, PA 18337
US
570-249-6000
About Manzo Pharmaceuticals, Inc.
Manzo Pharmaceuticals, Inc. is a specialized drug company that focuses on the discovery, creation, and evaluation of both proprietary and generic medical treatments and therapies. The company is actively developing Lacto-Freedom, a patented probiotic designed to help individuals with lactose intolerance digest dairy-containing foods more easily. Additionally, it is crafting a natural solution for infant colic. Headquartered in Milford, Pennsylvania, the organization was formerly known as Fortune Oil & Gas, Inc. before adopting its current name, Manzo Pharmaceuticals, Inc., in September 2014.
Latest News
No recent news
Recent Insider Trades
No insider trades found